LAMEA Electrophysiology Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Indication Type (Atrial Fibrillation, Atrial Flutter, AVNRT & WPW), By Country and Growth Forecast, 2022-2028

The Latin America, Middle East and Africa Electrophysiology Market is expected to witness market growth of 11.8% CAGR during the forecast period (2022-2028).

Over the last few years, advancements in the electrophysiology (EP) devices field have accelerated, pushing the boundaries of product innovation paradigms. The emergence of leadless pacemakers was one such overarching trend in the electrophysiology devices market. Leadless pacemakers are a good alternative to traditional pacemakers, especially for individuals who have had device infections in the past. Traditional pacemakers are becoming a major source of worry since they are linked to a significant risk of morbidity. As a result, a strong foundation is being laid for a "never seen before" acceptance of leadless pacemakers.

Another underlying trend in the electrophysiology devices market is well-known healthcare centers offering unique electrophysiology programs that is expected to address all treatment needs for heart rhythm abnormalities and related illnesses. UPMC Pinnacle, for example, is a premier healthcare center that provides a wide range of electrophysiological services. The most effective approach forward for companies to accelerate growth in the electrophysiological devices market remains to be effective remolding of product portfolios.

Due to the rapidly rising incidence of cardiovascular illnesses, LAMEA is expected to witness an increase in demand for electrophysiology market in the near future.   Key market players in the region are likely to increase their investment due to the region's fast increasing healthcare infrastructure & rising healthcare expenditure levels. This is also likely to result in the launch of novel electrophysiological devices in this area. The emergence of indigenous players is expected to result in fierce price competition, driving demand for low-cost gadgets in the region.

The expanding ageing population, technological advancements, and higher healthcare & advanced functionality funding are all driving the MEA electrophysiology market. Furthermore, the population is quickly ageing, increasing the risk of target diseases, cardiovascular diseases are on the rise in the region, and growing economies are driving market expansion. Technological improvements in electrophysiology will have a significant impact on the electrophysiology industry's growth.

The Brazil market dominated the LAMEA Electrophysiology Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $210.9 million by 2028. The Argentina market is poised to grow at a CAGR of 12.4% during (2022-2028). Additionally, The UAE market is expected to witness a CAGR of 11.5% during (2022-2028).

Based on Type, the market is segmented into Electrophysiology Laboratory Devices, Electrophysiology Diagnostic Catheters, Electrophysiology Ablation Catheters, Electrophysiology Access Devices, and Others. Based on Electrophysiology Laboratory Devices Type, the market is segmented into ICE Ultrasound Imaging Systems, Electrophysiology X-Ray Systems, Radiofrequency (RF) Ablation Systems, 3D Mapping Systems & Electrophysiology Recording Systems, and Electrophysiology Remote Magnetic & Robotic Navigation Systems. Based on Electrophysiology Diagnostic Catheters Type, the market is segmented into Conventional, Ultrasound, and Advanced. Based on Electrophysiology Ablation Catheters Type, the market is segmented into Laser, Cryoablation, and Radiofrequency (RF) & Microwave. Based on End User, the market is segmented into Hospitals & Cardiac centres, and Ambulatory Surgery Centers. Based on Indication type, the market is segmented into Atrial Fibrillation, Atrial Flutter, AVNRT & WPW, and Others.Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, General Electric (GE) Co. (GE Healthcare), Medtronic PLC, Koninklijke Philips N.V., Siemens Healthineers AG, Johnson & Johnson, MicroPort Scientific Corporation, Stereotaxis Inc., and Acutus Medical, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Electrophysiology Laboratory Devices
  • ICE Ultrasound Imaging Systems
  • Electrophysiology X-Ray Systems
  • Radiofrequency (RF) Ablation Systems
  • 3D Mapping Systems & Electrophysiology Recording Systems
  • Electrophysiology Remote Magnetic & Robotic Navigation Systems
• Electrophysiology Diagnostic Catheters
  • Conventional
  • Ultrasound
  • Advanced
• Electrophysiology Ablation Catheters
  • Laser
  • Cryoablation
  • Radiofrequency (RF) & Microwave
• Electrophysiology Access Devices
• Others

By End User

• Hospitals & Cardiac centres
• Ambulatory Surgery Centers

By Indication type

• Atrial Fibrillation
• Atrial Flutter
• AVNRT & WPW
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Boston Scientific Corporation
• General Electric (GE) Co. (GE Healthcare)
• Medtronic PLC
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Johnson & Johnson
• MicroPort Scientific Corporation
• Stereotaxis Inc.
• Acutus Medical, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free